Prevtec Microbia Receives European Marketing Authorization for Coliprotec® F4/F18 E. coli bivalent live vaccine

with Klifovet's support

"The approval of Coliprotec® F4/F18 is the result of strong teamwork between Prevtec Microbia and Klifovet AG, and following the introduction of our first vaccine Coliprotec® F4 more than a year ago, in the European Union, this new bivalent vaccine brings even more depth of prevention for swine producers and veterinarians" added Dr. Éric Nadeau, Vice-President Scientific Affairs. "We are delighted to bring Coliprotec® F4/F18 across Europe with our partner Elanco."

Read the full press release here!